New Stock News | Minyu Pharmaceutical Resubmits Application to Hong Kong Stock Exchange, Its own Immunotherapy Project Expected to Generate Revenue Soon.

According to the Zhitong Financial APP, as disclosed by the Hong Kong Stock Exchange on July 8, Mingyu Pharmaceutical Co., Ltd.-B (referred to as Mingyu Pharmaceutical) has once again submitted its application for listing on the main board of the Hong Kong Stock Exchange. Morgan Stanley, BofA Securities, and CITIC Securities are its joint sponsors.